Standex International Corp/De/
SXI NYSE Refrigeration & Service Industry Machinery Financials FY2017βFY2026
What Standex International Corp/De/ does
No business description yet.
- Legal name
- STANDEX INTERNATIONAL CORP/DE/
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K Β· Aug 14, 2026
- Accession Β· CIK
- 0001437749-26-027789
0000310354
Revenue and margins
Standex International Corp/De/ had $892M of revenue in fiscal 2026, up 12.8% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 10.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $64.4M in fiscal 2026, 7.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Standex International Corp/De/ returned $20.6M to shareholders in fiscal 2026, 32% of free cash flow. The diluted share count rose 0.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Standex International Corp/De/ can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $105M | $196M | $154M | $105M | $179M |
| Debt incl. finance leases | $175M | $173M | $149M | $553M | $518M |
| Net debt / EBITDA | 0.6x | β0.1x | β0.0x | 3.5x | 1.5x |
| Debt / equity | 0.4x | 0.3x | 0.2x | 0.8x | 0.7x |
| Interest coverage | 15.0x | 31.7x | 22.4x | 3.9x | 6.3x |
| Current ratio | 2.5x | 3.4x | 3.4x | 2.9x | 2.4x |
| Quick ratio | 1.8x | 2.7x | 2.7x | 2.1x | 1.8x |
| Total assets | $934M | $1.0B | $1.0B | $1.6B | $1.6B |
| Total liabilities | $435M | $417M | $384M | $855M | $830M |
| Shareholders' equity | $499M | $607M | $622M | $712M | $755M |
| Net debt (β = net cash) | $70.0M | β$22.3M | β$5.3M | $448M | $339M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 6 / 9 | 6 / 9 | 6 / 9 | 8 / 9 | 7 / 9 | 7 / 9 | 6 / 9 | 4 / 9 | 6 / 9 |
| Accruals ratio | β1.9% | β3.2% | β0.6% | β2.9% | β5.0% | β1.7% | 4.9% | β1.9% | β1.1% | 1.0% |
| Altman Z'' | 5.59 | 5.89 | 5.91 | 5.84 | 6.04 | 6.59 | 8.11 | 7.88 | 4.93 | 5.61 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $648M | $596M | $640M | $605M | $656M | $735M | $741M | $721M | $790M | $892M |
| Gross profit | $216M | $226M | $235M | $215M | $241M | $270M | $285M | $282M | $315M | $372M |
| Research and development | β | β | β | β | β | β | β | $20.5M | $21.2M | $24.2M |
| Operating income | $56.9M | $78.1M | $79.5M | $60.5M | $59.2M | $88.3M | $171M | $102M | $93.5M | $194M |
| Interest expense | $4.0M | $8.0M | $10.8M | $7.5M | $6.0M | $5.9M | $5.4M | $4.5M | $23.9M | $30.7M |
| Pretax income | $51.0M | $68.4M | $67.0M | $54.1M | $52.7M | $81.3M | $164M | $95.1M | $68.8M | $163M |
| Income tax | $11.8M | $38.0M | $18.7M | $13.1M | $14.2M | $19.8M | $24.8M | $21.5M | $11.1M | $34.3M |
| Net income | $46.5M | $36.6M | $67.9M | $20.2M | $36.5M | $61.4M | $139M | $73.1M | $55.8M | $105M |
| Diluted EPS | $3.65 | $2.86 | $5.38 | $1.63 | $2.97 | $5.06 | $11.58 | $6.14 | $4.64 | $8.67 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $63.4M | $64.9M | $73.3M | $47.2M | $83.6M | $77.7M | $90.8M | $92.7M | $69.6M | $89.6M |
| Capital expenditure | β | $23.6M | $32.5M | $21.5M | $21.8M | $23.9M | $24.3M | $20.3M | $28.3M | $25.2M |
| Free cash flow | β | $41.4M | $40.8M | $25.7M | $61.8M | $53.8M | $66.5M | $72.4M | $41.3M | $64.4M |
| Depreciation and amortization | $17.8M | $25.0M | $29.3M | $32.3M | $33.2M | $29.7M | $28.5M | $28.1M | $35.4M | $38.7M |
| Stock-based compensation | $5.0M | β | β | β | β | β | β | β | β | β |
| Acquisitions | $154M | $10.4M | $128M | $0.6M | $27.4M | $13.0M | $0.0M | $48.8M | $479M | $0.0M |
| Share buybacks | $7.8M | $2.7M | $33.4M | $10.4M | $21.2M | $31.4M | $25.5M | $31.8M | $9.9M | $4.4M |
| Dividends paid | $7.9M | $8.9M | $9.8M | $10.6M | $11.4M | $12.2M | $13.0M | $13.9M | $15.0M | $16.2M |
| Dividends and buybacks | $15.7M | $11.5M | $43.2M | $21.0M | $32.6M | $43.7M | $38.5M | $45.7M | $24.9M | $20.6M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $88.6M | $110M | $93.1M | $119M | $136M | $105M | $196M | $154M | $105M | $179M |
| Total debt | $192M | $194M | $198M | $199M | $199M | $175M | $173M | $149M | $553M | $518M |
| Current assets | $361M | $384M | $334M | $332M | $374M | $379M | $483M | $430M | $481M | $552M |
| Current liabilities | $160M | $161M | $142M | $123M | $144M | $151M | $141M | $128M | $167M | $230M |
| Inventory | $119M | $104M | $76.3M | $85.0M | $91.9M | $105M | $98.5M | $87.1M | $130M | $129M |
| Property and equipment, net | $133M | $137M | $134M | $133M | $133M | $129M | $131M | $135M | $160M | $153M |
| Goodwill | $243M | $204M | $274M | $271M | $278M | $268M | $265M | $281M | $610M | $582M |
| Intangible assets | $103M | $84.9M | $119M | $106M | $98.9M | $85.8M | $75.7M | $78.7M | $226M | $199M |
| Total assets | $868M | $917M | $922M | $931M | $962M | $934M | $1.0B | $1.0B | $1.6B | $1.6B |
| Total liabilities | $459M | $466M | $458M | $469M | $456M | $435M | $417M | $384M | $855M | $830M |
| Shareholders' equity | $409M | $451M | $464M | $462M | $506M | $499M | $607M | $622M | $712M | $755M |
| Margins | ||||||||||
| Gross margin | 33.3% | 38.0% | 36.7% | 35.6% | 36.8% | 36.7% | 38.5% | 39.1% | 39.9% | 41.7% |
| Operating margin | 8.8% | 13.1% | 12.4% | 10.0% | 9.0% | 12.0% | 23.1% | 14.1% | 11.8% | 21.7% |
| EBITDA margin | 11.5% | 17.3% | 17.0% | 15.4% | 14.1% | 16.0% | 26.9% | 18.0% | 16.3% | 26.0% |
| Net margin | 7.2% | 6.1% | 10.6% | 3.3% | 5.6% | 8.3% | 18.8% | 10.1% | 7.1% | 11.7% |
| FCF margin | β | 6.9% | 6.4% | 4.3% | 9.4% | 7.3% | 9.0% | 10.0% | 5.2% | 7.2% |
| Returns | ||||||||||
| Return on capital | 8.5% | 9.5% | 10.1% | 8.5% | 7.6% | 11.7% | 24.8% | 12.8% | 6.8% | 14.0% |
| Return on capital employed | 8.0% | 10.3% | 10.2% | 7.5% | 7.2% | 11.3% | 19.4% | 11.6% | 6.7% | 14.3% |
| Return on equity | 11.4% | 8.5% | 14.8% | 4.4% | 7.5% | 12.2% | 25.1% | 11.9% | 8.4% | 14.3% |
| Return on assets | 5.4% | 4.1% | 7.4% | 2.2% | 3.9% | 6.5% | 14.2% | 7.2% | 4.3% | 6.6% |
| Return on tangible equity | 73.3% | 22.6% | 94.6% | 24.0% | 28.2% | 42.1% | 52.1% | 27.9% | β | β |
| Growth | ||||||||||
| Revenue growth | β | β8.1% | 7.5% | β5.5% | 8.6% | 12.1% | 0.8% | β2.8% | 9.6% | 12.8% |
| Net income growth | β | β21.4% | 85.5% | β70.3% | 80.7% | 68.3% | 126.4% | β47.4% | β23.7% | 87.6% |
| EPS growth | β | β21.6% | 88.1% | β69.7% | 82.2% | 70.4% | 128.9% | β47.0% | β24.4% | 86.9% |
| FCF growth | β | β | β1.3% | β37.0% | 140.4% | β12.9% | 23.6% | 8.8% | β43.0% | 56.0% |
| Share count change | β | 0.2% | β1.2% | β1.9% | β1.0% | β1.1% | β0.9% | β0.9% | 0.9% | 0.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.4x | 0.8x | 1.0x | 0.9x | 0.7x | 0.6x | β0.1x | β0.0x | 3.5x | 1.5x |
| Debt / equity | 0.5x | 0.4x | 0.4x | 0.4x | 0.4x | 0.4x | 0.3x | 0.2x | 0.8x | 0.7x |
| Interest coverage | 14.1x | 9.7x | 7.4x | 8.1x | 9.9x | 15.0x | 31.7x | 22.4x | 3.9x | 6.3x |
| Current ratio | 2.3x | 2.4x | 2.4x | 2.7x | 2.6x | 2.5x | 3.4x | 3.4x | 2.9x | 2.4x |
| Quick ratio | 1.5x | 1.7x | 1.8x | 2.0x | 2.0x | 1.8x | 2.7x | 2.7x | 2.1x | 1.8x |
| Capital allocation | ||||||||||
| Capex / revenue | β | 4.0% | 5.1% | 3.6% | 3.3% | 3.2% | 3.3% | 2.8% | 3.6% | 2.8% |
| Stock comp / revenue | 0.8% | β | β | β | β | β | β | β | β | β |
| Payouts / FCF | β | 27.9% | 105.8% | 81.8% | 52.8% | 81.1% | 57.9% | 63.2% | 60.5% | 32.0% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 6.0 | 6.0 | 6.0 | 8.0 | 7.0 | 7.0 | 6.0 | 4.0 | 6.0 |
| Altman Z'' | 5.6 | 5.9 | 5.9 | 5.8 | 6.0 | 6.6 | 8.1 | 7.9 | 4.9 | 5.6 |
| Accruals ratio | β1.9% | β3.2% | β0.6% | β2.9% | β5.0% | β1.7% | 4.9% | β1.9% | β1.1% | 1.0% |
Source: SEC EDGAR XBRL filings (CIK 0000310354). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.